Fresh2 Group Ltd: Nasdaq/NYSE listing notice — Fresh2 Group receives Nasdaq deficiency notice for bid price below $1; 180-day cure period to July 24, 2024

Fresh2 Group Ltd

Received Nasdaq deficiency notice on Jan 26, 2024 for failing to maintain minimum $1 bid price for 30 consecutive business days.
Initial compliance period of 180 calendar days, until July 24, 2024, to regain compliance.
To regain compliance, ADS closing bid price must be at least $1.00 for 10 consecutive business days before deadline.
If not cured by July 24, company may qualify for additional 180-day period subject to other listing standards.
Company intends to monitor bid price and consider options including reverse stock split if necessary.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Fresh2 Group Ltd received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

January 26, 2024, Fresh2 Group Limited (the “Company”) received a deficiency notice (the “Notice”) from The Nasdaq Stock Market (“Nasdaq”) informing the Company that it failed to comply with the $1 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) based upon the closing bid price of the American Depositary Shares (“ADSs”) of the Company for the 30 consecutive business days prior to the date of the Notice from Nasdaq. Nasdaq’s Notice has no immediate effect on the listing of the Company’s ADSs on The Nasdaq Capital Market. Pursuan

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001213900-24-007478

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.